McNeice Paul Francis sold $1K of AMWL

McNeice Paul Francis (Chief Accounting Officer) sold 112 shares of American Well Corp (AMWL) at $9.74 on 2026-06-01.

Original reporting
SEC EDGAR · McNeice Paul Francis
Published Jun 3, 2026, 8:57 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 3, 2026, 9:02 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AMWL
Neutral
high confidence
Mentioned
$AMWL
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMWLNeutralLow
01

Why it matters

The disclosure updates the insider-trading record but does not introduce new operational, financial, or regulatory information.

02

Market read

Traders may note the insider sale for sentiment monitoring, but it is unlikely to drive a fundamental repricing on its own.

03

What to watch

Insider sales can be driven by taxes, diversification, or pre-scheduled personal needs; without context on total holdings/compensation, directional inference is weak.

Relevance 4/10Novelty 7/10Timing: Filed 2026-06-03; sale occurred 2026-06-01

Background

This is an SEC Form 4 insider transaction disclosure (officer/direct holdings) for American Well Corp.

Company-level read

Ticker impact

$AMWLNeutralHigh confidence
Context

Chief Accounting Officer McNeice Paul Francis sold 112 shares of AMWL on 2026-06-01, disclosed via SEC Form 4.

Expected impact

Limited near-term impact; any reaction is likely small and sentiment-driven.

Evidence & confidence

The filing is a routine Form 4 insider transaction with small absolute value (~$1.1k) and no accompanying corporate event or guidance change.

Market effects

No clear sector read-through; this is company-specific insider activity without broader industry catalyst.

None.

None.

Counterpoint

The sale may be routine liquidity/compensation-related and not a bearish signal, especially given the lack of a 10b5-1 plan mention and small dollar amount.

Key entities

  • American Well Corp

    Subject of the Form 4 insider transaction disclosure.

  • McNeice Paul Francis

    Chief Accounting Officer who sold AMWL shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AMWLMed

American Well Corp (AMWL) Q3 2026 Earnings Call Highlights: Revenue Beat, Raised Guidance

American Well Corp (AMWL) reported Q3 2026 revenue of $49M, down 12.9% YoY. Subscription revenue fell 22.5% due to churn. Platform visits dropped 30.5% YoY. The VA letter of intent is non-binding, and the DHA contract conversion is pending. CEO Dr. Ido Schoenberg expressed optimism about negotiations and potential growth opportunities. The company expects Q4 adjusted EBITDA breakeven and raised guidance.

$AMWLMedAI 8/10

What American Well (AMWL) Said on Its Q3 Earnings Call

Amwell (AMWL) reported Q3 earnings with virtual primary care visits up 41% YoY, but total platform visits down 30.5%. Gross profit was $26M with a 53% margin. Q4 revenue is forecasted at $48M-$50M, with adjusted EBITDA expected to break even or turn positive. The company raised its full-year 2026 outlook, now expecting revenue of $204M-$206M and a reduced adjusted EBITDA loss. Amwell also discussed potential government contracts, including a nonbinding letter of intent from the VA.

$AMWLHigh

American Well Corp (AMWL): AMWELL® ANNOUNCES RESULTS FOR THE third QUARTER 2026

American Well Corp (AMWL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 AMWELL® ANNOUNCES RESULTS FOR THE third QUARTER 2026 BOSTON, November 3 , 2026 –Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the third quarter ended September 30,

$AMWLMedAI 8/10

American Well (AMWL) Q2 2026 Earnings Call Transcript

American Well (AMWL) reported Q2 2026 revenue of $52 million, down 26.6% year over year, with subscription revenue of $25.7 million and AMG revenue of $24.4 million. Adjusted EBITDA loss was $1.15 million and net loss was $9.6 million. Full-year guidance was narrowed to $200-$205 million revenue and improved adjusted EBITDA loss to $9-$7 million. The Defense Health Agency issued an intent to award a sole-source contract.